Vilon (20 mg Vial) Dosage Protocol
Vilon (Lys-Glu) is a synthetic dipeptide bioregulator targeting immune cells, studied in Russian protocols for immune modulation, thymic function, and age-related immunosenescence.
⚡ Quickstart Highlights
Dosing & Reconstitution Guide
Educational guide for reconstitution and pulsed dosing
Standard / Gradual Approach (3 mL = ~6.67 mg/mL)
| Phase / Cycle | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Cycle 1, Day 1 | 67 mcg (0.067 mg) | 1 unit (0.01 mL) |
| Cycle 1, Day 2 | 133 mcg (0.133 mg) | 2 units (0.02 mL) |
| Cycle 1, Day 3 | 200 mcg (0.20 mg) | 3 units (0.03 mL) |
| Cycle 1, Day 4 | 267 mcg (0.267 mg) | 4 units (0.04 mL) |
| Cycle 1, Day 5 | 333 mcg (0.33 mg) | 5 units (0.05 mL) |
| Cycle 2+ (Days 1–5) | 333–667 mcg (0.33–0.67 mg) | 5–10 units (0.05–0.10 mL) |
Frequency: Inject once daily subcutaneously for 5 consecutive days, then rest for the remainder of a 4‑week cycle. Repeat monthly.
For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; follow product-specific use-by instructions; do not assume freezing extends stability.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–16 week pulsed protocol (5 injection days per 4‑week cycle).
| Item | Quantity |
|---|---|
| Peptide Vials (Vilon, 20 mg each) | 8 weeks (2 cycles, 10 injections) ≈ 1 vial 12 weeks (3 cycles, 15 injections) ≈ 1 vial 16 weeks (4 cycles, 20 injections) ≈ 1 vial |
| Insulin Syringes (U‑100, 30‑ or 50‑unit preferred) | Per cycle: 5 syringes (1/day × 5 days) 8 weeks: 10 syringes 12 weeks: 15 syringes 16 weeks: 20 syringes |
| Bacteriostatic Water (10 mL bottles) | 8–16 weeks (1 vial): 3 mL → 1 × 10 mL bottle |
| Alcohol Swabs | Per cycle: 10 swabs (2/day × 5 days) 8 weeks: 20 swabs 12 weeks: 30 swabs 16 weeks: 40 swabs → recommend 1 × 100‑count box |
Protocol Overview
The hypothesized gene-expression mechanism produces effects that persist months after the cycle ends, supporting the cycled rather than continuous approach. Evidence base is primarily Russian gerontology and clinical research; peer-reviewed Western data is limited.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | Up to 24 months, dry & dark |
| Reconstituted | 2–8°C (35–46°F) | Up to 30 days, protect from light |
Important Notes
How This Works
Vilon is a Khavinson-class peptide bioregulator hypothesized to modulate T-cell function and thymic gene expression, supporting immune competency in aged populations.
Potential Benefits & Side Effects
Potential Benefits
- Immune modulation in Russian clinical protocols.
- Studied for age-related immune decline (immunosenescence).
- May pair with Thymosin Alpha-1 in immune-support stacks.
Side Effect Profile
- Generally well-tolerated in Russian clinical literature.
- Mild injection-site reactions.
- Limited peer-reviewed Western data.
Lifestyle Factors
- Adequate sleep and rest during cycles.
- Balanced nutrition supports cellular repair.
Injection Technique
- Subcutaneous, rotate sites daily during 20-day cycle.